Takeda’s clinical trial website provides a central, transparent resource for exploring Takeda‑sponsored clinical studies. With the clinical trial search tool, you can easily explore Takeda‑sponsored studies and access useful information on:
- Specific diseases or therapeutic areas
- Available clinical studies in your region
- Study Inclusion and exclusion criteria, as well as key study design elements
- Summaries of study results (after study completion)
The website is available in English and offers convenient translation options into multiple languages, including German, French, and Italian.
Visit our website: https://clinicaltrials.takeda.com
VOICE - Ongoing Study Factsheet
A prospective, observational study to explore the time course of early response to newly-prescribed vedolizumab treatment, as measured by patient-reported outcomes measures.
VERDICT - Ongoing Study Factsheet
An ongoing phase 4, multicenter, prospective, randomized trial to determine optimal treatment targets in patients with ulcerative colitis.
VARSITY Study Factsheet
The objective of the VARSITY study is to evaluate the comparative efficacy and safety of vedolizumab versus adalimumab in adults with moderately to severely active ulcerative colitis, using a randomized, double‑blind, double‑dummy, active‑controlled phase 3b study design.
GEMINI LTS Study Factsheet
A phase 3, single-arm, open-label, multinational study to evaluate the safety of long-term vedolizumab treatment in moderately to severely active Crohn's disease and ulcerative colitis.
Key milestone studies
This infographic shows aims and conclusions as part of a detailed timeline of key milestone studies for the treatment of ulcerative colitis, Crohn’s disease, and pouchitis.
